- 4 February 2014
- journal article
- review article
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 11 (2) , 212-219
Abstract
In heart failure (HF), the progressive use of multiple drugs and a complex therapeutic regimen is common and is recommended by international guidelines. With HF being a common disease in the elderly, patients often have numerous comorbidities that require additional specific treatment, thus producing a heavy pill burden. Polypharmacy, defined as the chronic use of five or more medications, is an underestimated problem in the management of HF patients. However, polypharmacy has an important impact on HF treatment, as it often leads to inappropriate drug prescription, poor adherence to pharmacological therapies, drug-drug interactions, and adverse effects. The growing complexity of HF patients, whose mean age increases progressively and who present multiple comorbidities, suggests the need for newer models of primary care to improve the management of HF patients. Self-care, telemonitoring, and natriuretic peptide-guided therapy represent promising new HF care models to face the complexity of the disease and its therapeutic regimen.Keywords
This publication has 66 references indexed in Scilit:
- The Implications of Therapeutic Complexity on Adherence to Cardiovascular MedicationsArchives of internal medicine (1960), 2011
- Trends in Comorbidity, Disability, and Polypharmacy in Heart FailureThe American Journal of Medicine, 2011
- B-Type Natriuretic Peptide–Guided Heart Failure TherapyArchives of internal medicine (1960), 2010
- Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United StatesJAMA, 2008
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)European Heart Journal, 2008
- Polypharmacy and Prescribing Quality in Older PeopleJournal of the American Geriatrics Society, 2006
- Specialist Care of Heart Failure Improves Appropriate Pharmacotherapy at the Expense of Greater Polypharmacy and Drug-InteractionsEuropean Journal of Heart Failure, 2004
- Spectrum of heart failure in older patients: Results from the national heart failure projectAmerican Heart Journal, 2002
- Antiplatelet Agents and Survival: A Cohort Analysis From the Studies of Left Ventricular Dysfunction (SOLVD) TrialJACC, 1998
- Optimising drug treatment for elderly people: the prescribing cascadeBMJ, 1997